Repligen Corp (RGEN) stock
RGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 7/30122% above fair value
$176.94−11.70 (-6.20%)
Close on Oct 30, 2026Market cap $9.99BP/E –Yield –
Earnings
Repligen's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$209.30M
+10.7% on a year earlier
adjusted EPS, Q3 FY2026
$0.53
$0.46 a year earlier
Latest guidance
Raised
Oct 27, 2026 · 10 items
Quarterly results
Revenue and earnings per share from each of Repligen's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 23, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 27, 2026before the open | $209.30M | +10.7% | -$0.68 | $0.53 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 28, 2026before the open | $204.00M | +12.1% | $0.09 | $0.54 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026before the open | $194.00M | +14.8% | $0.15 | $0.48 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 24, 2026before the open | $198.00M | +17.9% | $0.23 | $0.49 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 28, 2025before the open | $189.00M | +21.9% | $0.26 | $0.46 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 29, 2025before the open | $182.00M | +18.2% | $0.26 | $0.37 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 29, 2025before the open | $169.00M | +11.7% | $0.10 | $0.39 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 20, 2025before the open | $168.00M | +7.9% | -$0.60 | $0.44 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024before the open | $155.00M | +9.8% | -$0.01 | $0.43 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 30, 2024before the open | $154.00M | -3.3% | $0.06 | $0.33 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 1, 2024before the open | $151.30M | -17.2% | $0.04 | $0.28 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 21, 2024before the open | $155.70M | -16.6% | – | $0.33 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 31, 2023before the open | $141.20M | -29.6% | $0.32 | $0.23 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023before the open | $159.20M | -23.3% | $0.35 | $0.53 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 2, 2023before the open | $182.70M | -11.5% | $0.51 | $0.64 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 22, 2023before the open | $186.80M | +0.2% | $0.85 | $0.68 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 1, 2022before the open | $200.70M | +12.6% | $0.71 | $0.77 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 2, 2022before the open | $207.60M | – | $0.88 | $0.91 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 27, 2022before the open | $206.40M | – | $0.81 | $0.92 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 17, 2022before the open | $186.50M | – | $0.50 | $0.81 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 28, 2021before the open | $178.20M | – | $0.58 | $0.78 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 27, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 4, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 24, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Repligen's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Reported Growthnon-GAAP | FY2026 | +9% – +13% | +10% – +14% | Reaffirmed | May 5, 2026 |
| Total Reported Revenuenon-GAAP | FY2026 | $844.00M – $852.00M | $813.00M – $835.00M | Raised | Oct 27, 2026 |
| Total Reported Revenuenon-GAAP | FY2026 | $803.00M – $833.00M | $810.00M – $840.00M | Lowered | May 5, 2026 |
| Gross Marginnon-GAAP | FY2026 | 53.7% – 54.2% | 53.7% – 54.2% | Reaffirmed | Oct 27, 2026 |
| Gross Marginnon-GAAP | FY2026 | 53.7% – 54.2% | 53.6% – 54.1% | Raised | May 5, 2026 |
| Income from Operationsnon-GAAP | FY2026 | $135.00M – $139.00M | $128.00M – $134.00M | Raised | Oct 27, 2026 |
| Income from Operationsnon-GAAP | FY2026 | $124.00M – $132.00M | $122.00M – $130.00M | Raised | May 5, 2026 |
| Operating Marginnon-GAAP | FY2026 | 16% – 16.3% | 15.7% – 16% | Raised | Oct 27, 2026 |
| Operating Marginnon-GAAP | FY2026 | 15.4% – 15.8% | 15.1% – 15.5% | Raised | May 5, 2026 |
| Adjusted EBITDA Marginnon-GAAP | FY2026 | 21% | 20.6% – 21% | Raised | Oct 27, 2026 |
| Adjusted EBITDA Marginnon-GAAP | FY2026 | 20% – 20.5% | – | New | Feb 24, 2026 |
| Earnings Per Share - Dilutednon-GAAP | FY2026 | $2.05 – $2.09 | $2.03 – $2.09 | Raised | Oct 27, 2026 |
| Earnings Per Share - Dilutednon-GAAP | FY2026 | $1.97 – $2.05 | $1.93 – $2.01 | Raised | May 5, 2026 |
| Adjusted EBITDA Marginnon-GAAP | FY2026 | 20.3% – 20.8% | – | Lowered | May 5, 2026 |
| Net Incomenon-GAAP | FY2026 | $119.00M – $122.00M | $115.50M – $118.50M | Raised | Oct 27, 2026 |
| Net Incomenon-GAAP | FY2026 | $111.50M – $116.50M | $109.00M – $114.00M | Raised | May 5, 2026 |
| Organic Growthnon-GAAP | FY2026 | +12% – +13% | +10.5% – +13.5% | Narrowed | Oct 27, 2026 |
| Other Income (Expense)non-GAAP | FY2026 | $18.00M | $19.00M | Lowered | Oct 27, 2026 |
| Other Income (Expense)non-GAAP | FY2026 | $19.00M | $18.00M | Lowered | May 5, 2026 |
| Reported Growthnon-GAAP | FY2026 | +10% – +13% | – | New | Jul 28, 2026 |
| Tax Rate on Pre-Tax Incomenon-GAAP | FY2026 | 22% | 22% | Reaffirmed | Oct 27, 2026 |
| Tax Rate on Pre-Tax Incomenon-GAAP | FY2026 | 22% – 23% | 22% – 23% | Raised | May 5, 2026 |
Guidance vs results
The last range Repligen gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | EPS (GAAP) | $0.82 – $0.85 | $0.85Σ4Q | Within range |
| FY2025 | Revenue | $729.00M – $737.00M | $738.00MΣ4Q | Above range |
| FY2025 | Revenue growth | +15% – +16% | +17.46%Σ4Q | Above range |
Guidance history
Every forecast Repligen put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 27, 2026 | Adjusted EBITDA Margin | FY2026 | 21% | Raised |
| Oct 27, 2026 | Earnings Per Share - Diluted | FY2026 | $2.05 – $2.09 | Raised |
| Oct 27, 2026 | Gross Margin | FY2026 | 53.7% – 54.2% | Reaffirmed |
| Oct 27, 2026 | Income from Operations | FY2026 | $135.00M – $139.00M | Raised |
| Oct 27, 2026 | Operating Margin | FY2026 | 16% – 16.3% | Raised |
| Oct 27, 2026 | Other Income (Expense) | FY2026 | $18.00M | Lowered |
| Oct 27, 2026 | Organic Growth | FY2026 | +12% – +13% | Narrowed |
| Oct 27, 2026 | Tax Rate on Pre-Tax Income | FY2026 | 22% | Reaffirmed |
| Oct 27, 2026 | Net Income | FY2026 | $119.00M – $122.00M | Raised |
| Oct 27, 2026 | Total Reported Revenue | FY2026 | $844.00M – $852.00M | Raised |
| Jul 28, 2026 | Adjusted EBITDA Margin | FY2026 | 20.6% – 21% | New |
| Jul 28, 2026 | Earnings Per Share - Diluted | FY2026 | $2.03 – $2.09 | New |
| Jul 28, 2026 | Gross Margin | FY2026 | 53.7% – 54.2% | New |
| Jul 28, 2026 | Income from Operations | FY2026 | $128.00M – $134.00M | New |
| Jul 28, 2026 | Operating Margin | FY2026 | 15.7% – 16% | New |
| Jul 28, 2026 | Reported Growth | FY2026 | +10% – +13% | New |
| Jul 28, 2026 | Tax Rate on Pre-Tax Income | FY2026 | 22% | New |
| Jul 28, 2026 | Organic Growth | FY2026 | +10.5% – +13.5% | Raised |
| Jul 28, 2026 | Other Income (Expense) | FY2026 | $19.00M | New |
| Jul 28, 2026 | Net Income | FY2026 | $115.50M – $118.50M | Raised |
| Jul 28, 2026 | Total Reported Revenue | FY2026 | $813.00M – $835.00M | New |
| May 5, 2026 | Earnings Per Share - Diluted | FY2026 | $1.97 – $2.05 | Raised |
| May 5, 2026 | Gross Margin | FY2026 | 53.7% – 54.2% | Raised |
| May 5, 2026 | Income from Operations | FY2026 | $124.00M – $132.00M | Raised |
| May 5, 2026 | Operating Margin | FY2026 | 15.4% – 15.8% | Raised |
| May 5, 2026 | Adjusted EBITDA Margin | FY2026 | 20.3% – 20.8% | Lowered |
| May 5, 2026 | Tax Rate on Pre-Tax Income | FY2026 | 22% – 23% | Raised |
| May 5, 2026 | Other Income (Expense) | FY2026 | $19.00M | Lowered |
| May 5, 2026 | Net Income | FY2026 | $111.50M – $116.50M | Raised |
| May 5, 2026 | Reported Growth | FY2026 | +9% – +13% | Reaffirmed |
| May 5, 2026 | Organic Growth | FY2026 | +9% – +13% | Reaffirmed |
| May 5, 2026 | Total Reported Revenue | FY2026 | $803.00M – $833.00M | Lowered |
| Feb 24, 2026 | Adjusted EBITDA Margin | FY2026 | 20% – 20.5% | New |
| Feb 24, 2026 | Earnings Per Share - Diluted | FY2026 | $1.93 – $2.01 | New |
| Feb 24, 2026 | Gross Margin | FY2026 | 53.6% – 54.1% | New |
| Feb 24, 2026 | Income from Operations | FY2026 | $122.00M – $130.00M | New |
| Feb 24, 2026 | Operating Margin | FY2026 | 15.1% – 15.5% | New |
| Feb 24, 2026 | Tax Rate on Pre-Tax Income | FY2026 | 22% – 23% | New |
| Feb 24, 2026 | Other Income (Expense) | FY2026 | $18.00M | New |
| Feb 24, 2026 | Net Income | FY2026 | $109.00M – $114.00M | Raised |
| Feb 24, 2026 | Reported Growth | FY2026 | +10% – +14% | New |
| Feb 24, 2026 | Organic Growth | FY2026 | +9% – +13% | Lowered |
| Feb 24, 2026 | Total Reported Revenue | FY2026 | $810.00M – $840.00M | New |
| Oct 28, 2025 | Earnings Per Share - Diluted | FY2025 | $0.82 – $0.85 | New |
| Oct 28, 2025 | Gross Margin | FY2025 | 51.5% – 52.5% | New |
| Oct 28, 2025 | Income from Operations | FY2025 | $50.00M – $52.00M | New |
| Oct 28, 2025 | Operating Margin | FY2025 | 7% | New |
| Oct 28, 2025 | Tax Rate on Pre-Tax Income | FY2025 | 17% – 18% | New |
| Oct 28, 2025 | Other Income (Expense) | FY2025 | $7.50M | New |
| Oct 28, 2025 | Net Income | FY2025 | $46.50M – $48.00M | Raised |
| Oct 28, 2025 | Reported Growth | FY2025 | +15% – +16% | New |
| Oct 28, 2025 | Reported Growth | FY2025 | +15% – +16% | New |
| Oct 28, 2025 | Total Reported Revenue | FY2025 | $729.00M – $737.00M | New |
| Oct 28, 2025 | Total Reported Revenue | FY2025 | $729.00M – $737.00M | New |
| Feb 20, 2025 | Adjusted EBITDA Margin | FY2025 | 20% – 21% | New |
| Feb 20, 2025 | Earnings Per Share - Diluted | FY2025 | $1.67 – $1.76 | New |
| Feb 20, 2025 | Earnings Per Share - Diluted | FY2025 | $0.90 – $0.99 | New |
| Feb 20, 2025 | Gross Margin | FY2025 | 51% – 52% | New |
| Feb 20, 2025 | Gross Margin | FY2025 | 51% – 52% | New |
| Feb 20, 2025 | Income from Operations | FY2025 | $59.00M – $66.00M | New |
| Feb 20, 2025 | Income from Operations | FY2025 | $99.00M – $106.00M | New |
| Feb 20, 2025 | Operating Margin | FY2025 | 8% – 9% | New |
| Feb 20, 2025 | Operating Margin | FY2025 | 14% – 15% | New |
| Feb 20, 2025 | Tax Rate on Pre-Tax Income | FY2025 | 23% – 24% | New |
| Feb 20, 2025 | Tax Rate on Pre-Tax Income | FY2025 | 22% – 23% | New |
| Feb 20, 2025 | Other Income (Expense) | FY2025 | $15.00M – $16.00M | New |
| Feb 20, 2025 | Net Income | FY2025 | $51.00M – $56.00M | Raised |
| Feb 20, 2025 | Other Income (Expense) | FY2025 | $23.00M – $24.00M | New |
| Feb 20, 2025 | Net Income | FY2025 | $95.00M – $100.00M | Raised |
| Feb 20, 2025 | Reported Growth | FY2025 | +8% – +12% | New |
| Feb 20, 2025 | Reported Growth | FY2025 | +8% – +12% | New |
| Feb 20, 2025 | Organic Growth | FY2025 | +9.5% – +13.5% | Raised |
| Feb 20, 2025 | Non-COVID Revenue Growth | FY2025 | +10% – +14% | Raised |
| Feb 20, 2025 | Total Reported Revenue | FY2025 | $685.00M – $710.00M | New |
| Feb 20, 2025 | Total Reported Revenue | FY2025 | $685.00M – $710.00M | New |
| Nov 12, 2024 | Earnings Per Share—Diluted | FY2024 | $1.50 – $1.58 | Raised |
| Nov 12, 2024 | Earnings Per Share—Diluted | FY2024 | $0.25 – $0.32 | Raised |
| Nov 12, 2024 | Gross Margin | FY2024 | 49.5% – 50.5% | Raised |
| Nov 12, 2024 | Gross Margin | FY2024 | 49.5% – 50.5% | Raised |
| Nov 12, 2024 | Income from Operations | FY2024 | $12.00M – $17.00M | Reaffirmed |
| Nov 12, 2024 | Income from Operations | FY2024 | $80.00M – $85.00M | Raised |
| Nov 12, 2024 | Operating Margin | FY2024 | 2% – 3% | Reaffirmed |
| Nov 12, 2024 | Operating Margin | FY2024 | 12.5% – 13.5% | Raised |
| Nov 12, 2024 | Tax Rate on Pre-Tax Income | FY2024 | 33% | Lowered |
| Nov 12, 2024 | Adjusted EBITDA Margin | FY2024 | 17.5% – 18.5% | Lowered |
| Nov 12, 2024 | Tax Rate on Pre-Tax Income | FY2024 | 20% | Raised |
| Nov 12, 2024 | Year-over-Year Change | FY2024 | 0% – +1% | Raised |
| Nov 12, 2024 | Year-over-Year Change | FY2024 | 0% – +1% | Raised |
| Nov 12, 2024 | Base Revenue Growth | FY2024 | -1% – 0% | Lowered |
| Nov 12, 2024 | Other Income (Expense) | FY2024 | $10.00M | Narrowed |
| Nov 12, 2024 | Net Income | FY2024 | $14.00M – $18.00M | Raised |
| Nov 12, 2024 | Other Income (Expense) | FY2024 | $27.00M | Lowered |
| Nov 12, 2024 | Net Income | FY2024 | $85.00M – $89.00M | Raised |
| Nov 12, 2024 | Total Reported Revenue | FY2024 | $630.00M – $639.00M | Raised |
| Nov 12, 2024 | Total Reported Revenue | FY2024 | $630.00M – $639.00M | Raised |
| Jul 30, 2024 | Adjusted EBITDA Margin | FY2024 | 17% – 18% | Lowered |
| Jul 30, 2024 | Earnings Per Share - Diluted | FY2024 | $1.42 – $1.49 | Reaffirmed |
| Jul 30, 2024 | Earnings Per Share - Diluted | FY2024 | $0.17 – $0.24 | Lowered |
| Jul 30, 2024 | Gross Margin | FY2024 | 49% – 50% | Reaffirmed |
| Jul 30, 2024 | Gross Margin | FY2024 | 49% – 50% | Reaffirmed |
| Jul 30, 2024 | Income from Operations | FY2024 | $12.00M – $17.00M | Lowered |
| Jul 30, 2024 | Income from Operations | FY2024 | $76.00M – $81.00M | Lowered |
| Jul 30, 2024 | Operating Margin | FY2024 | 2% – 3% | Lowered |
| Jul 30, 2024 | Operating Margin | FY2024 | 12% – 13% | Lowered |
| Jul 30, 2024 | Tax Rate on Pre-Tax Income | FY2024 | 35% | Raised |
| Jul 30, 2024 | Tax Rate on Pre-Tax Income | FY2024 | 20% | Lowered |
| Jul 30, 2024 | Year-over-Year Change | FY2024 | -3% – -1% | Lowered |
| Jul 30, 2024 | Year-over-Year Change | FY2024 | -3% – -1% | Lowered |
| Jul 30, 2024 | Base Revenue Growth | FY2024 | -1% – +1% | Raised |
| Jul 30, 2024 | Other Income (Expense) | FY2024 | $5.00M | Lowered |
| Jul 30, 2024 | Net Income | FY2024 | $9.50M – $13.50M | Raised |
| Jul 30, 2024 | Other Income (Expense) | FY2024 | $24.00M | Lowered |
| Jul 30, 2024 | Net Income | FY2024 | $80.00M – $84.00M | Raised |
| Jul 30, 2024 | Total Reported Revenue | FY2024 | $620.00M – $635.00M | Lowered |
| Jul 30, 2024 | Total Reported Revenue | FY2024 | $620.00M – $635.00M | Lowered |
| May 1, 2024 | Adjusted EBITDA Margin | FY2024 | 18% – 19% | New |
| May 1, 2024 | Earnings Per Share - Diluted | FY2024 | $1.42 – $1.49 | New |
| May 1, 2024 | Earnings Per Share - Diluted | FY2024 | $0.51 – $0.58 | New |
| May 1, 2024 | Gross Margin | FY2024 | 49% – 50% | New |
| May 1, 2024 | Gross Margin | FY2024 | 49% – 50% | New |
| May 1, 2024 | Income from Operations | FY2024 | $83.00M – $88.00M | New |
| May 1, 2024 | Income from Operations | FY2024 | $38.50M – $43.50M | New |
| May 1, 2024 | Operating Margin | FY2024 | 13% – 14% | New |
| May 1, 2024 | Operating Margin | FY2024 | 6% – 7% | New |
| May 1, 2024 | Tax Rate on Pre-Tax Income | FY2024 | 23% | New |
| May 1, 2024 | Year-over-Year Change | FY2024 | -3% – +2% | New |
| May 1, 2024 | Year-over-Year Change | FY2024 | -3% – +2% | New |
| May 1, 2024 | Base Revenue Growth | FY2024 | -1% – +4% | Raised |
| May 1, 2024 | Other Income (Expense) | FY2024 | -$1.00M – $0 | New |
| May 1, 2024 | Net Income | FY2024 | $28.50M – $32.50M | Raised |
| May 1, 2024 | Other Income (Expense) | FY2024 | $18.00M – $19.00M | New |
| May 1, 2024 | Net Income | FY2024 | $80.00M – $84.00M | Raised |
| May 1, 2024 | Tax Rate on Pre-Tax Income | FY2024 | 21% | New |
| May 1, 2024 | Total Reported Revenue | FY2024 | $620.00M – $650.00M | New |
| May 1, 2024 | Total Reported Revenue | FY2024 | $620.00M – $650.00M | New |
| Oct 31, 2023 | Earnings Per Share - Diluted | FY2023 | $1.70 – $1.76 | Lowered |
| Oct 31, 2023 | Earnings Per Share - Diluted | FY2023 | $1.26 – $1.32 | Raised |
| Oct 31, 2023 | Gross Margin | FY2023 | 45.5% – 46.5% | Lowered |
| Oct 31, 2023 | Gross Margin | FY2023 | 49% – 50% | Lowered |
| Oct 31, 2023 | Income from Operations | FY2023 | $61.00M – $65.00M | Raised |
| Oct 31, 2023 | Income from Operations | FY2023 | $96.00M – $100.00M | Lowered |
| Oct 31, 2023 | Operating Margin | FY2023 | 10% – 11% | New |
| Oct 31, 2023 | Operating Margin | FY2023 | 15% – 16% | Lowered |
| Oct 31, 2023 | Total Reported Revenue | FY2023 | $635.00M – $645.00M | Lowered |
| Oct 31, 2023 | Total Reported Revenue | FY2023 | $635.00M – $645.00M | New |
| Aug 2, 2023 | Adjusted net income per share (non-GAAP) | FY2023 | $1.72 – $1.80 | Lowered |
| Aug 2, 2023 | Net income per share (GAAP) | FY2023 | $1.00 – $1.08 | Lowered |
| Aug 2, 2023 | Gross margin | FY2023 | 49.5% – 50.5% | Lowered |
| Aug 2, 2023 | Gross margin | FY2023 | 50% – 51% | Lowered |
| Aug 2, 2023 | Income from operations | FY2023 | $57.00M – $63.00M | Lowered |
| Aug 2, 2023 | Adjusted (non-GAAP) income from operations | FY2023 | $104.00M – $110.00M | Lowered |
| Aug 2, 2023 | Adjusted operating margin | FY2023 | 16% – 17% | Lowered |
| Aug 2, 2023 | Net income | FY2023 | $57.00M – $61.00M | Lowered |
| Aug 2, 2023 | Adjusted (non-GAAP) net income | FY2023 | $98.00M – $102.00M | Lowered |
| Aug 2, 2023 | Total reported revenue | FY2023 | $635.00M – $665.00M | Lowered |
| May 2, 2023 | Adjusted net income per share (non-GAAP) | FY2023 | $2.35 – $2.42 | Lowered |
| May 2, 2023 | Net income per share (GAAP) | FY2023 | $1.70 – $1.77 | Lowered |
| May 2, 2023 | Gross margin | FY2023 | 52% – 53% | Lowered |
| May 2, 2023 | Gross margin | FY2023 | 52% – 53% | Lowered |
| May 2, 2023 | Income from operations | FY2023 | $111.00M – $116.00M | Lowered |
| May 2, 2023 | Adjusted (non-GAAP) income from operations | FY2023 | $153.00M – $158.00M | Lowered |
| May 2, 2023 | Adjusted operating margin | FY2023 | 20.5% – 21.5% | New |
| May 2, 2023 | base business growth | FY2023 | +4% – +8% | New |
| May 2, 2023 | COVID-related revenue | FY2023 | $30.00M – $40.00M | New |
| May 2, 2023 | Net income | FY2023 | $97.00M – $101.00M | Lowered |
| May 2, 2023 | Adjusted (non-GAAP) net income | FY2023 | $134.00M – $138.00M | Lowered |
| May 2, 2023 | Total reported revenue | FY2023 | $720.00M – $760.00M | New |
| Feb 22, 2023 | Adjusted net income per share (non-GAAP) | FY2023 | $2.61 – $2.69 | New |
| Feb 22, 2023 | Net income per share (GAAP) | FY2023 | $1.96 – $2.04 | New |
| Feb 22, 2023 | Gross margin | FY2023 | 52.5% – 53.5% | New |
| Feb 22, 2023 | Gross margin | FY2023 | 52.5% – 53.5% | New |
| Feb 22, 2023 | Income from operations | FY2023 | $135.00M – $141.00M | New |
| Feb 22, 2023 | Adjusted (non-GAAP) income from operations | FY2023 | $176.00M – $182.00M | New |
| Feb 22, 2023 | Operating margin | FY2023 | 22.5% – 23.5% | New |
| Feb 22, 2023 | Net income | FY2023 | $112.00M – $117.00M | New |
| Feb 22, 2023 | Adjusted (non-GAAP) net income | FY2023 | $149.00M – $154.00M | New |
| Feb 22, 2023 | base organic revenue growth | FY2023 | +12% – +16% | New |
| Feb 22, 2023 | Total reported revenue | FY2023 | $760.00M – $800.00M | New |
| Nov 1, 2022 | Adjusted (non-GAAP) fully diluted EPS | FY2022 | $3.15 – $3.20 | Raised |
| Nov 1, 2022 | Fully diluted GAAP EPS | FY2022 | $2.76 – $2.81 | Raised |
| Nov 1, 2022 | Gross margin | FY2022 | 57.5% – 58.5% | Reaffirmed |
| Nov 1, 2022 | Gross margin | FY2022 | 57.5% – 58.5% | Reaffirmed |
| Nov 1, 2022 | Income from operations | FY2022 | $203.00M – $207.00M | Raised |
| Nov 1, 2022 | Adjusted (non-GAAP) income from operations | FY2022 | $231.00M – $235.00M | Lowered |
| Nov 1, 2022 | Net income | FY2022 | $158.00M – $161.00M | Raised |
| Nov 1, 2022 | Adjusted (non-GAAP) net income | FY2022 | $181.00M – $184.00M | Raised |
| Nov 1, 2022 | Total reported revenue | FY2022 | $795.00M – $805.00M | Narrowed |
| Aug 2, 2022 | Adjusted (non-GAAP) fully diluted EPS | FY2022 | $3.13 – $3.20 | Raised |
| Aug 2, 2022 | Fully diluted GAAP EPS | FY2022 | $2.64 – $2.71 | Raised |
| Aug 2, 2022 | Gross margin | FY2022 | 57.5% – 58.5% | Raised |
| Aug 2, 2022 | Gross margin | FY2022 | 57.5% – 58.5% | Raised |
| Aug 2, 2022 | Income from operations | FY2022 | $200.00M – $205.00M | Raised |
| Aug 2, 2022 | Adjusted (non-GAAP) income from operations | FY2022 | $234.00M – $239.00M | Raised |
| Aug 2, 2022 | Net income | FY2022 | $152.00M – $156.00M | Raised |
| Aug 2, 2022 | Adjusted (non-GAAP) net income | FY2022 | $180.00M – $184.00M | Raised |
| Aug 2, 2022 | Total revenue | FY2022 | $790.00M – $810.00M | Raised |
| Apr 27, 2022 | Adjusted (non-GAAP) fully diluted EPS | FY2022 | $3.07 – $3.15 | Lowered |
| Apr 27, 2022 | Fully diluted GAAP EPS | FY2022 | $2.41 – $2.49 | Raised |
| Apr 27, 2022 | Gross margin | FY2022 | 57% – 58% | Reaffirmed |
| Apr 27, 2022 | Gross margin | FY2022 | 57% – 58% | Reaffirmed |
| Apr 27, 2022 | Income from operations | FY2022 | $180.00M – $186.00M | Lowered |
| Apr 27, 2022 | Adjusted (non-GAAP) income from operations | FY2022 | $225.00M – $231.00M | Lowered |
| Apr 27, 2022 | Net income | FY2022 | $139.00M – $144.00M | Raised |
| Apr 27, 2022 | Adjusted (non-GAAP) net income | FY2022 | $177.00M – $182.00M | Lowered |
| Apr 27, 2022 | Total revenue | FY2022 | $770.00M – $800.00M | Lowered |
| Feb 17, 2022 | Adjusted (non-GAAP) fully diluted EPS | FY2022 | $3.21 – $3.30 | New |
| Feb 17, 2022 | Fully diluted GAAP EPS | FY2022 | $2.39 – $2.48 | New |
| Feb 17, 2022 | Gross margin | FY2022 | 57% – 58% | New |
| Feb 17, 2022 | Gross margin | FY2022 | 57% – 58% | New |
| Feb 17, 2022 | Income from operations | FY2022 | $184.00M – $190.00M | New |
| Feb 17, 2022 | Adjusted (non-GAAP) income from operations | FY2022 | $234.00M – $240.00M | New |
| Feb 17, 2022 | Net income | FY2022 | $138.00M – $143.00M | New |
| Feb 17, 2022 | Adjusted (non-GAAP) net income | FY2022 | $185.00M – $190.00M | New |
| Feb 17, 2022 | Total revenue | FY2022 | $800.00M – $830.00M | New |
| Oct 28, 2021 | Adjusted (non-GAAP) fully diluted EPS | FY2021 | $2.86 – $2.91 | New |
| Oct 28, 2021 | Fully diluted GAAP EPS | FY2021 | $2.19 – $2.24 | New |
| Oct 28, 2021 | Gross margin | FY2021 | 59% – 60% | New |
| Oct 28, 2021 | Gross margin | FY2021 | 59% – 60% | New |
| Oct 28, 2021 | Income from operations | FY2021 | $165.00M – $169.00M | New |
| Oct 28, 2021 | Adjusted (non-GAAP) income from operations | FY2021 | $204.00M – $208.00M | New |
| Oct 28, 2021 | Total revenue | FY2021 | $655.00M – $665.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Repligen filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- Results
- Update
- Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial GuidanceResults
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results